XOMA Corporation (XOMA)
-NasdaqGM 5.16 
0.67(14.92%) Oct 1, 4:00PM EDT|After Hours
:
4.48 0.68 (13.18%) Oct 1, 6:20PM EDT
| Prev Close: | 4.49 |
|---|
| Open: | 4.49 |
|---|
| Bid: | N/A |
|---|
| Ask: | 5.30 x 1000 |
|---|
| 1y Target Est: | 6.69 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | 4-Nov-13 |
|---|
| Day's Range: | 4.47 - 5.20 |
|---|
| 52wk Range: | 2.37 - 5.53 |
|---|
| Volume: | 2,758,074 |
|---|
| Avg Vol (3m): | 1,045,370 |
|---|
| Market Cap: | 429.10M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Nasdaq stocks posting largest percentage increasesAP(Tue, Oct 1)
- How one bull is staying with XomaoptionMONSTER(Tue, Oct 1)
- XOMA Ltd.'s Management Presents at Morgan Stanley Healthcare Conference (Transcript)at Seeking Alpha(Wed, Sep 11)
- XOMA to Present at the Morgan Stanley Healthcare ConferenceGlobeNewswire(Thu, Sep 5)
- The Baker Brothers Increase Shares In Halozyme By 105%, Insider Makes Big Buy And Options Heat Upat Seeking Alpha(Wed, Aug 28)
- How volatility trade is playing XomaoptionMONSTER(Tue, Aug 27)
- Largest option trades in equitiesoptionMONSTER(Tue, Aug 27)
- XOMA Raises FundsZacks(Mon, Aug 26)
- XOMA Announces Closing of the Offering and Exercise of Over-Allotment OptionGlobeNewswire(Fri, Aug 23)
- XOMA Prices OfferingZacks(Wed, Aug 21)
- XOMA CORP Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online(Wed, Aug 21)
- Xoma Floats New Stock Issueat Motley Fool(Tue, Aug 20)
- XOMA Announces Pricing of $27.5 Million Offering of Common StockGlobeNewswire(Tue, Aug 20)
- XOMA CORP FinancialsEDGAR Online Financials(Thu, Aug 15)
- XOMA to Present at Two Upcoming Investor ConferencesGlobeNewswire(Thu, Aug 8)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 11.95 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.89 |
|---|
| Quarterly EPS Est
(Sep-13)
: | -0.20 |
|---|
| Mean Recommendation*: | 1.7 |
|---|
| PEG Ratio (5 yr expected): | -0.26 |
|---|
Business Summary
XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company offers ACEON, an angiotensin converting enzyme inhibitor.
View More